It has been demonstrated that inhibition of PLK1 renders glioblastoma and non-small cell lung cancer cells sensitive to IR (Pezuk et al., 2013; Van den Bossche et al., 2019). Here, PLK1 is linked to non-small cell lung carcinoma.